Cargando…
Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice
Obesity is well known to be a major cause of several chronic metabolic diseases, which can be partially counteracted by exercise. This is due, in part, to an upregulation of mitochondrial activity through increased nicotinamide adenine dinucleotide (NAD(+)). Recent studies have shown that NAD(+) lev...
Autores principales: | Uddin, Golam M., Youngson, Neil A., Sinclair, David A., Morris, Margaret J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990541/ https://www.ncbi.nlm.nih.gov/pubmed/27594836 http://dx.doi.org/10.3389/fphar.2016.00258 |
Ejemplares similares
-
Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise
por: Uddin, Golam Mezbah, et al.
Publicado: (2017) -
Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers
por: Uddin, Golam M., et al.
Publicado: (2020) -
NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023) -
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
por: Di Stefano, M, et al.
Publicado: (2015) -
Safety Evaluation for Restorin® NMN, a NAD+ Precursor
por: Turner, John, et al.
Publicado: (2021)